SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.

MLA

Shields, Adrian M., et al. “SARS-CoV-2 Vaccine Responses Following CD20-Depletion Treatment in Patients with Haematological and Rheumatological Disease: A West Midlands Research Consortium Study.” Clinical and Experimental Immunology, vol. 207, no. 1, Jan. 2022, pp. 3–10. EBSCOhost, https://doi.org/10.1093/cei/uxab018.

APA

Shields, A. M., Venkatachalam, S., Shafeek, S., Paneesha, S., Ford, M., Sheeran, T., Kelly, M., Qureshi, I., Salhan, B., Karim, F., De Silva, N., Stones, J., Lee, S., Khawaja, J., Kaudlay, P. K., Whitmill, R., Kakepoto, G. N., Parry, H. M., Moss, P., … Basu, S. (2022). SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study. Clinical and Experimental Immunology, 207(1), 3–10. https://doi.org/10.1093/cei/uxab018

Chicago

Shields, Adrian M, Srinivasan Venkatachalam, Salim Shafeek, Shankara Paneesha, Mark Ford, Tom Sheeran, Melanie Kelly, et al. 2022. “SARS-CoV-2 Vaccine Responses Following CD20-Depletion Treatment in Patients with Haematological and Rheumatological Disease: A West Midlands Research Consortium Study.” Clinical and Experimental Immunology 207 (1): 3–10. doi:10.1093/cei/uxab018.